undefined undefined
NaN.000
NaN.00%
Cullinan Therapeutics (NASDAQ:CGEM) drew Wall Street's attention last week as William Blair touted the stock after peer-reviewed data for Amgen's (NASDAQ:AMGN) leukemia therapy, Blincyto, which target...
04-28 03:39
JERSEY CITY, N.J., April 24, 2024 /PRNewswire/ -- Veris Residential, Inc. (NYSE: VRE) (the "Company"), a forward-thinking, environmentally and socially conscious multifamily REIT, today repo...
04-25 04:20
Cramer's comments came amid a positive outlook for several tech stocks heading into the week.
03-21 19:21
Allogene Therapeutics (NASDAQ:ALLO) reported its Q4 earnings results on Thursda...
03-15 04:20
Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.46) by 10.87 percent. This is a 23.88 percent increase over losses of $(0.67) per
03-15 04:17
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
03-14 17:52
Allogene Therapeutics (NASDAQ:ALLO) is set to give its latest quarterly earning...
03-14 02:01
Allogene's AlloCAR T Autoimmune Disease Platform Leverages Arbor's CRISPR Gene-...
03-12 20:57
JP Morgan analyst Brian Cheng maintains Allogene Therapeutics (NASDAQ:ALLO) with a Overweight and lowers the price target from $9 to $8.
02-28 02:18
Reports Record Full Year Revenues, Adjusted EBITDA, and Adjusted Unlevered Free Cash Flow Expands Scale and Reach of the Instructure Platform by Acquiring Parchment, the World's Leading Cred...
02-21 05:05